LINALIGIP EMPAMET

Linaligip Empamet is a triple-combination diabetes tablet. Type 2 diabetes is a progressive condition, and many people eventually need more than one medicine to keep blood sugar in the target range. This tablet puts three well-established drugs into one dose, which simplifies the routine.

1. Empagliflozin (SGLT2 inhibitor). The kidneys normally reabsorb glucose back into the blood. Empagliflozin blocks the SGLT2 transporter in the kidney, so extra glucose is passed out in the urine. This lowers blood sugar independently of insulin. It also brings modest weight loss and a small fall in blood pressure. In large clinical trials, empagliflozin also lowered the risk of cardiovascular death and heart failure hospitalisation in people with type 2 diabetes and established heart disease, and it has shown kidney-protective benefits.

2. Linagliptin (DPP-4 inhibitor). After meals, the gut releases hormones called incretins that raise insulin and lower glucagon. The enzyme DPP-4 breaks these hormones down quickly. Linagliptin blocks DPP-4, so the incretin effect lasts longer. This helps the body release insulin only when blood sugar is high, so the risk of low sugar is small. Linagliptin is cleared mainly through the gut rather than the kidneys, so it does not usually need a dose adjustment in kidney impairment.

3. Metformin Hydrochloride ER (biguanide). Metformin is the foundation of type 2 diabetes treatment. It reduces the amount of glucose the liver produces and makes the body's tissues respond better to insulin. The extended-release form releases the drug slowly, which improves stomach tolerance and allows once-daily dosing.

Why combine them? Each drug lowers blood sugar through a different route: the kidney (empagliflozin), the gut-pancreas hormone pathway (linagliptin), and the liver and muscle (metformin). Together, they usually lower HbA1c more than any one alone, without relying on medicines that commonly cause hypoglycaemia.

Product Information 

Why Is This Combination Important?

India has one of the largest populations of people with diabetes in the world, and many are diagnosed at a younger age than in the West. Persistent high blood sugar slowly damages the eyes, kidneys, nerves, heart, and blood vessels. Many patients stay above target on one or two drugs, and delays in stepping up therapy lead to avoidable complications.

A triple combination like this is important for five reasons:

1. It helps patients reach targets. When two medicines are not enough, adding a third drug from a different class often brings HbA1c down further.
2. It lowers the tablet burden. One tablet a day replaces three separate medicines, which supports adherence. Many people with diabetes already take several other tablets for blood pressure and cholesterol.
3. It carries a low risk of hypoglycaemia on its own. None of the three components usually causes low blood sugar when used without insulin or sulfonylureas.
4. It offers benefits beyond sugar control. Empagliflozin has cardiovascular, heart failure, and kidney evidence, and it also helps with weight and blood pressure.
5. It is practical in kidney impairment. Linagliptin needs no renal dose change, though the overall combination still has kidney limits because of metformin and empagliflozin.

Steris Healthcare manufactures Linaligip Empamet under WHO-GMP and ISO-certified quality systems, so diabetologists, physicians, pharmacists, and distributors get consistent quality.

Key Benefits 

• Strong HbA1c reduction: Three complementary mechanisms lower both fasting and after-meal sugar.
• Low hypoglycaemia risk: When used without insulin or sulfonylureas, low sugar is uncommon.
• Weight-friendly: Empagliflozin promotes modest weight loss, and metformin is weight-neutral. Linagliptin does not add weight.
• Modest blood pressure lowering: A small fall in blood pressure comes from empagliflozin.
• Cardiovascular and kidney evidence: Empagliflozin has proven benefit in selected patients with heart or kidney disease.
• Once-daily convenience: Extended-release metformin and long-acting partners allow a single daily dose.
• Better stomach tolerance: The ER form of metformin causes less gastrointestinal upset than immediate-release metformin for many people.
• Compact 15-tablet strip: Covers 15 days of therapy and is easy to store and carry.

Uses of Linaligip Empamet

• Type 2 diabetes mellitus in adults, as an add-on to diet and exercise, when treatment with all three components is appropriate
• Patients already taking empagliflozin, linagliptin, and metformin separately, to replace them with a single tablet
• Patients who need additional control after dual therapy, as decided by the doctor

Precautions Before Taking 

Tell your doctor your full medical history before starting this medicine.

Do not use if:

• You have type 1 diabetes or have had diabetic ketoacidosis
• You have severe kidney impairment (eGFR below 30), kidney failure, or you are on dialysis
• You have acute or unstable conditions that can affect the kidneys or cause lack of oxygen, such as severe infection, dehydration, shock, recent heart attack, or heart failure that is decompensated
• You have significant liver disease
• You have a history of lactic acidosis
• You are allergic to empagliflozin, linagliptin, metformin, or any ingredient in the tablet, including a history of serious reactions such as angioedema to a DPP-4 inhibitor
• You are pregnant or breastfeeding, unless your doctor decides otherwise

Use with caution and tell your doctor if you have:

• Dehydration risk, such as vomiting, diarrhoea, poor fluid intake, or use of diuretics
• Low blood pressure or you are on blood pressure medicines
• Recurrent urinary tract infections or genital fungal infections
• Pancreatitis history (gallstones, heavy alcohol use, very high triglycerides)
• Heart failure, particularly if you take other DPP-4 medicines. Empagliflozin is generally helpful in heart failure, but discuss this with your doctor.
• Insulin or sulfonylurea use. The doctor may lower their dose to reduce the risk of hypoglycaemia.
• A history of foot ulcers or poor circulation
• Heavy alcohol intake
• Planned contrast dye scans (CT or angiography), since metformin may need to be paused around the procedure
• Vitamin B12 deficiency or anaemia. Long-term metformin use can lower B12.
• Older age (65 and above)

Side Effects

Many people tolerate this combination well. Side effects tend to depend on which component is responsible.

Common:

• Genital yeast infections (itching, redness, discharge) in women and men
• Urinary tract infections
• Increased urination and thirst
• Nausea, diarrhoea, stomach upset, or bloating (mostly from metformin, and usually improves with food)
• Metallic taste
• Runny nose or sore throat (upper respiratory tract symptoms)
• Mild dizziness on standing (from fluid loss)

Less common:

• Low blood sugar, mainly if combined with insulin or a sulfonylurea
• Dehydration and low blood pressure
• Joint pain
• Skin rash or itching
• Low vitamin B12 with long-term metformin use
• Increased cholesterol (LDL) with empagliflozin

Frequently Asked Questions

Where can I buy Empagliflozin Linagliptin and Metformin online?

Empagliflozin, Linagliptin and Metformin can be purchased online through licensed pharmacies or authorized medicine suppliers in India, subject to availability and prescription requirements.

What is the price of Empagliflozin Linagliptin and Metformin?

The price may vary depending on the brand, strength, dosage form, pack size, manufacturer, and seller. Check the current product listing for the latest price.

Can I order Empagliflozin Linagliptin and Metformin online?

Yes, this combination may be ordered online through an authorized pharmacy or licensed supplier, provided the product is available and any applicable prescription requirements are met.

Is Empagliflozin Linagliptin and Metformin available from Steris Healthcare?

Availability from Steris Healthcare depends on the current product range and stock status. Contact Steris Healthcare or check its latest product listing for availability and ordering information.

What is Empagliflozin Linagliptin and Metformin used for?

Empagliflozin, Linagliptin and Metformin is a combination of antidiabetic medicines used to help control blood glucose levels in adults with type 2 diabetes, along with diet and exercise, when prescribed by a healthcare professional.

What is the composition of Empagliflozin Linagliptin and Metformin?

The combination contains three active ingredients: Empagliflozin, Linagliptin, and Metformin. The exact strengths and formulation can vary by product, so check the product packaging or prescription for specific composition details.

Is a prescription required?

Empagliflozin, Linagliptin and Metformin is generally a prescription medicine. It should be used under the guidance of a qualified healthcare professional, who can determine whether it is appropriate for you.

How should Empagliflozin Linagliptin and Metformin be taken?

Take this medicine exactly as prescribed by your healthcare professional. Follow the recommended dose and timing, and do not change or stop treatment without medical advice. The tablet should be taken according to the instructions for your specific formulation.

What should I know before buying Empagliflozin Linagliptin and Metformin?

Before buying, check the exact strengths, dosage form, pack size, manufacturer, expiry date, and authenticity of the product. Inform your healthcare professional about your medical history and all medicines or supplements you take.

How can I order Empagliflozin Linagliptin and Metformin online?

To order online, select a licensed pharmacy or authorized supplier, verify the product strength and pack size, provide a prescription if required, and complete the seller's ordering and payment process.